Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep 04/14/2017 INTERVENTIONAL unchanged 3,421.85 0 VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer 04/19/2017 INTERVENTIONAL unchanged 3,416.85 0 Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years 04/20/2017 INTERVENTIONAL unchanged 3,415.85 0 Vagal Stimulation in POTS 04/21/2017 INTERVENTIONAL unchanged 3,414.85 0 Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer 04/24/2017 INTERVENTIONAL unchanged 3,411.85 0 Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence 04/25/2017 INTERVENTIONAL unchanged 3,410.85 0 Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI 05/02/2017 OBSERVATIONAL unchanged 3,403.85 0 Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO) 05/03/2017 INTERVENTIONAL unchanged 3,402.85 0 Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer 05/05/2017 INTERVENTIONAL unchanged 3,400.85 0 PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women 05/09/2017 OBSERVATIONAL unchanged 3,396.85 0 Early Detection of Breast Cancer in Women With Suspicious Mammograms 05/10/2017 OBSERVATIONAL unchanged 3,395.85 0 Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial 05/12/2017 INTERVENTIONAL unchanged 3,393.85 0 IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy 05/12/2017 INTERVENTIONAL unchanged 3,393.85 0 Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women 05/23/2017 INTERVENTIONAL unchanged 3,382.85 0 Comparison of the Breast Tumor Microenvironment 05/24/2017 OBSERVATIONAL unchanged 3,381.85 0 CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) 05/30/2017 INTERVENTIONAL unchanged 3,375.85 0 A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer 05/30/2017 INTERVENTIONAL unchanged 3,375.85 0 Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study 06/08/2017 INTERVENTIONAL unchanged 3,366.85 0 Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment 06/08/2017 INTERVENTIONAL unchanged 3,366.85 0 UTHealth Turner Syndrome Research Registry 06/14/2017 OBSERVATIONAL unchanged 3,360.85 0 A National Registry on Chinese Patients With Lymphangioleiomyomatosis 06/21/2017 OBSERVATIONAL unchanged 3,353.85 0 Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women 06/28/2017 INTERVENTIONAL unchanged 3,346.85 0 The Ma'Anshan Birth Cohort (MABC) 07/12/2017 OBSERVATIONAL unchanged 3,332.85 0 Intraoperative Radiation Therapy (IORT) in DCIS 07/13/2017 INTERVENTIONAL unchanged 3,331.85 0 Perioperative Music Listening on Anxiety, Analgesia Use and Patient Satisfaction 07/21/2017 INTERVENTIONAL unchanged 3,323.85 0 An Examination of Infants' Microbiome, Nutrition, and Development Study. 07/26/2017 INTERVENTIONAL unchanged 3,318.85 0 Oxytocin and Fetal Heart Rate Changes 07/28/2017 INTERVENTIONAL unchanged 3,316.85 0 Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer 07/28/2017 INTERVENTIONAL unchanged 3,316.85 0 Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy 08/03/2017 INTERVENTIONAL unchanged 3,310.85 0 Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer 08/04/2017 INTERVENTIONAL unchanged 3,309.85 0 Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer 08/15/2017 INTERVENTIONAL unchanged 3,298.85 0 Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE) 08/17/2017 INTERVENTIONAL unchanged 3,296.85 0 Uterus Transplantation From a Multi-organ Donor 08/17/2017 INTERVENTIONAL unchanged 3,296.85 0 Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer 08/21/2017 INTERVENTIONAL unchanged 3,292.85 0 PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) 08/21/2017 INTERVENTIONAL unchanged 3,292.85 0 The INFLUENCE of Cytoreduction on PRO in EOC 08/31/2017 OBSERVATIONAL unchanged 3,282.85 0 Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer 09/01/2017 INTERVENTIONAL unchanged 3,281.85 0 Her2-BATS and Pembrolizumab in Metastatic Breast Cancer 09/05/2017 INTERVENTIONAL unchanged 3,277.85 0 HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy 09/07/2017 INTERVENTIONAL unchanged 3,275.85 0 Maternal Autoimmune Disease Research Alliance (MADRA) Registry 09/08/2017 OBSERVATIONAL unchanged 3,274.85 0 Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer 09/11/2017 INTERVENTIONAL unchanged 3,271.85 0 Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction 09/13/2017 INTERVENTIONAL unchanged 3,269.85 0 Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy 09/13/2017 OBSERVATIONAL unchanged 3,269.85 0 Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. 09/14/2017 INTERVENTIONAL unchanged 3,268.85 0 The French E3N Prospective Cohort Study 09/15/2017 OBSERVATIONAL unchanged 3,267.85 0 CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer 09/18/2017 INTERVENTIONAL unchanged 3,264.85 0 Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments 09/20/2017 INTERVENTIONAL unchanged 3,262.85 0 Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer 09/20/2017 INTERVENTIONAL unchanged 3,262.85 0 Subclinical Lymphedema Treatment Study 09/25/2017 INTERVENTIONAL unchanged 3,257.85 0 Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS) 09/25/2017 INTERVENTIONAL unchanged 3,257.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology